Gearing up for the European Society for Medical Oncology (ESMO24) Congress with OBiS Insights Free Pre-Meeting Report
OBiS Insights pre-meeting ESMO24 report is based on a review of the 2,960 abstract titles of which 275 new not yet approved drugs have been profiled. NEW YORK, NY, UNITED STATES, September 12, 2024 /EINPresswire.com/ -- OBiS, a New York City-based …